Plus Therapeutics Inc. (PSTV)
0.66
-0.06 (-8.97%)
At close: Mar 03, 2025, 3:59 PM
0.66
-0.33%
After-hours: Mar 03, 2025, 07:08 PM EST
Plus Therapeutics Cash Flow Statement
Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 | FY10 | FY09 | FY08 | FY07 | FY06 | FY05 | FY04 | FY03 | FY02 | FY01 | FY00 | FY99 | FY98 |
Net Income | -13.32M | -20.27M | -13.4M | -8.24M | -10.89M | -12.63M | -22.69M | -22.05M | -18.74M | -37.37M | -26.18M | -32.28M | -32.45M | -27.49M | -23.22M | -30.04M | -28.67M | -25.45M | -26.54M | -2.09M | -9.13M | -13M | -11.21M | -8.64M | -4.57M | -2.09M |
Depreciation & Amortization | 628K | 619K | 395K | 366K | 896K | 2M | 2.15M | 1.18M | 1.09M | 779K | 1.63M | 933K | 855K | 931K | 1.68M | 1.71M | 1.62M | 2.12M | 1.72M | 824K | 1.66M | 1.47M | 1.18M | 441K | n/a | n/a |
Stock-Based Compensation | 569K | 606K | 606K | 247K | 127K | 355K | 753K | 1.08M | 2.04M | 3.1M | 3.61M | 3.9M | 3.32M | 3.06M | 2.65M | 2.31B | 2.31B | 3.22B | 404M | 119M | 997M | 1.3B | 1.14B | n/a | n/a | n/a |
Other Working Capital | 2.56M | -855K | -496K | 77K | 29K | 90K | -600K | -391K | -286K | 1.15B | 405.81M | 1.43B | 1.43B | -809.45M | 2.21B | -2.05B | -5.48M | -871.57M | -3.05B | -35.82M | -283.4M | 316.97M | -20.95M | -328K | n/a | n/a |
Other Non-Cash Items | 384K | 481K | 820K | 1.37M | 1.79M | 1.05M | 2.39M | 978K | 1.34M | 1.8M | 1.1M | 930K | -35.59M | -795K | 4.29M | 3.39M | 2.31M | -666K | 3.03M | -13.52M | -692K | 5.54M | 2.81M | 6.69M | -536K | 567K |
Deferred Income Tax | n/a | n/a | 60K | -2.29M | 3.1M | -1.72M | 298K | 45K | -7.5M | 995K | -9.86M | 440K | 33.37M | 854K | 753K | -2.31B | -2.31B | -3.22B | -404M | -119M | -997M | -1.3B | -1.14B | n/a | n/a | n/a |
Change in Working Capital | -1.12M | 5.6M | 1.24M | 119K | -938K | -1.03M | -1.04M | -772K | 1.3M | 364K | -4.86M | -6.12M | -4.83M | -125K | -9.97M | -8.5M | -3.5M | 7.44M | 20.68M | 2.21M | 920K | -893K | -1.1M | -1.47M | n/a | n/a |
Operating Cash Flow | -12.85M | -12.97M | -10.28M | -8.43M | -5.91M | -11.97M | -18.13M | -19.53M | -20.47M | -30.33M | -34.56M | -32.19M | -35.32M | -23.57M | -23.81M | -33.39M | -30M | -16.48M | -1.1M | -12.57M | -7.25M | -6.89M | -8.32M | -2.98M | -5.11M | -1.52M |
Capital Expenditures | -160K | -509K | -144K | -493K | -67K | -133K | -1.5M | -67K | -624K | -1.02M | -519K | -1.2M | -560K | -610K | -221K | -393K | -563K | -3.14M | -1.85M | -789K | -1.74M | -909K | -2.66M | -2.73M | n/a | n/a |
Acquisitions | n/a | -250K | 62K | -400K | 5.64M | n/a | 113K | 131K | 11K | n/a | 5M | n/a | n/a | n/a | n/a | -2.57B | 3.17M | 150M | n/a | -28K | -654K | -2.9M | 1B | n/a | n/a | n/a |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -330K | -5.74B | -5.74M | -24.33M | -63.41M | -54.06M | -50.32M | -41.27M | -56.97M | -85.14M | -122.33M | n/a | n/a |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 5.74B | 5.74M | 28.01M | 67.14M | 56.82M | 51.13M | 49.56M | 68.15M | 90.06M | 85.61M | n/a | n/a |
Other Investing Acitivies | n/a | -250K | 62K | 400K | 5.64M | n/a | -212K | 131K | 11K | -324K | -800K | n/a | n/a | -350K | n/a | 2.57B | -305K | -150M | 1K | 13.43M | 57K | 9.88M | -1B | n/a | -381K | -598K |
Investing Cash Flow | -160K | -759K | -82K | -493K | 5.57M | -133K | -1.71M | 64K | -613K | -1.34M | 3.69M | -1.2M | -560K | -1.29M | -221K | -393K | 5.98M | 591K | 911K | 13.43M | 5.95M | 17.27M | 2.26M | -39.45M | -381K | -598K |
Debt Repayment | -1.61M | -1.61M | -276K | -5.42M | -3.82M | n/a | -4.72M | n/a | -7.33M | -1.96M | 4.7M | -2.69M | 4.92M | 14.55M | -2.05M | 6.03M | -1.2M | -352K | 444K | 192K | 694K | -1.42M | 2.23M | -105K | n/a | n/a |
Common Stock Repurchased | -126K | n/a | n/a | n/a | n/a | n/a | -2.08M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -1.34M | -850K | n/a | n/a | n/a | -1.05M | -2.27M | -7.44M | -1.08M | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -75K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | -348K | -773K | 2.02M | 1.1M | 490K | -66K | n/a | -3.86M | -850K | 13.84M | 16.08M | -69K | 1.94M | 4.65M | 531K | 795K | -1.6M | n/a | n/a | n/a | n/a | n/a | 1.28B | 4.09M | 7.92M | 1.84M |
Financial Cash Flow | 3.44M | 13.45M | 20.42M | -319K | 12.63M | 7.17M | 16.82M | 17.61M | 20.8M | 30.87M | 20.77M | 22.19M | 20.14M | 64.68M | 24.27M | 34.93M | 26.58M | 16.79M | 5.36M | -831K | -997K | -7.97M | 1.28M | 47.44M | 7.92M | 1.84M |
Net Cash Flow | -9.57M | -280K | 10.05M | -9.25M | 12.29M | -4.92M | -3.01M | -1.78M | -284K | -884K | -10.21M | -11.21M | -15.75M | 39.81M | 243K | 1.15M | 2.56M | 895K | 5.17M | 20K | -2.29M | 2.41M | -4.78M | 5M | 7.92M | 1.84M |
Free Cash Flow | -13.01M | -13.48M | -10.42M | -8.93M | -5.97M | -12.11M | -19.62M | -19.6M | -21.09M | -31.35M | -35.08M | -33.4M | -35.88M | -24.18M | -24.03M | -33.78M | -30.56M | -19.62M | -2.95M | -13.36M | -8.99M | -7.79M | -10.99M | -5.71M | -5.11M | -1.52M |